Learning new techniques against lymphomas
Researchers have published on a new CAR-T cell therapy using CXCR5
Daily News
Kiromic completes GMP manufacturing facility
Kiromic completes GMP manufacturing facility
Kiromic’s GMP manufacturing facility in Houston will support the company’s first-in-human allogenic CAR-T trial
Thermo Fisher Scientific buys Henogen from Novasep
Thermo Fisher Scientific buys Henogen from Novasep
Acquisition will expand Thermo Fisher’s global capacity for cell and gene therapies
A new pathway against glioblastoma
A new pathway against glioblastoma
Researchers have linked a cellular transport pathway to glioblastoma multiforme
Maximum attention on minimal residual disease
Maximum attention on minimal residual disease
GRAIL announces collaborations with three industry giants to evaluate its platform in cancer MRD testing
bluebird’s oncology business takes wing
bluebird’s oncology business takes wing
Company shares plans to spin out oncology business and retain severe genetic disease business
PacBio, Invitae set sights on whole-genome sequencing
PacBio, Invitae set sights on whole-genome sequencing
The companies are aiming to develop a new production-scale platform to expand clinical adoption of whole-genome sequencing
Latest Issue
• Volume 17 • Issue 1 • January 2021
December 2020/January 2021
December 2020/January 2021 issue